## **Core Concept**
The question tests understanding of hypersensitivity reactions, specifically in the context of organ transplantation and rejection. Hyperacute rejection of a renal transplant is an immediate and severe form of rejection that occurs within minutes to hours after transplantation. It is primarily mediated by pre-existing antibodies against the graft.

## **Why the Correct Answer is Right**
The correct answer, **Type II hypersensitivity reaction**, is right because hyperacute rejection involves the binding of pre-existing antibodies (usually IgM or IgG) to antigens on the endothelial cells of the graft's blood vessels. This binding activates the complement system and leads to thrombosis, ischemia, and rapid graft failure. Type II hypersensitivity reactions are characterized by antibody-dependent cytotoxicity, where antibodies directly target cell surface antigens, leading to cell destruction.

## **Why Each Wrong Option is Incorrect**
- **Option A (Type I hypersensitivity reaction):** This is incorrect because Type I reactions involve IgE antibodies and the release of histamine and other mediators from mast cells, leading to allergic reactions. This mechanism does not primarily mediate hyperacute transplant rejection.
- **Option C (Type III hypersensitivity reaction):** This is incorrect because Type III reactions involve the formation of antigen-antibody complexes that deposit in tissues, activating complement and leading to inflammation. While immune complexes can play a role in some transplant reactions, they are not the primary mechanism in hyperacute rejection.
- **Option D (Type IV hypersensitivity reaction):** This is incorrect because Type IV reactions are cell-mediated and involve T lymphocytes. They are more commonly associated with chronic rejection or graft-versus-host disease rather than the immediate hyperacute rejection seen in renal transplants.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that hyperacute rejection is often due to ABO blood group incompatibility or pre-existing antibodies against human leukocyte antigens (HLA). This can sometimes be mitigated by cross-matching donor and recipient blood before transplantation. The speed of onset and the involvement of pre-formed antibodies make Type II hypersensitivity the correct mechanism.

## **Correct Answer: B. Type II hypersensitivity reaction**